Therapeutic Pipeline Program: Pre-clinical Studies
Event details
| Date | 28.09.2021 |
| Category | Call for proposal |
| Event Language | English |
Aim: This funding program — an Edmond J. Safra Core Program for PD Research — will support development of Parkinson’s disease (PD) therapeutics with potential for fundamentally altering disease course or significantly improving non-motor or motor symptoms.
Program Priorities:
Researchers from public and private institutions are encouraged to apply and to collaborate.
Deadline: Pre-proposals due 28 September 2021
Amount: Up to $500,000
Duration: 1 to 2 years
Eligibility: Applications may be submitted by researchers or clinicians in:
How to Apply:
Program Priorities:
- Assay development, early screening campaigns, hit-to-lead and lead optimization
- Proof-of-concept
- Pharmacokinetics, pharmacodynamics and safety
Researchers from public and private institutions are encouraged to apply and to collaborate.
Deadline: Pre-proposals due 28 September 2021
Amount: Up to $500,000
Duration: 1 to 2 years
Eligibility: Applications may be submitted by researchers or clinicians in:
- U.S. and non-U.S. biotechnology/pharmaceutical companies, or other publicly or privately held for-profit entities; and
- U.S. and non-U.S. public and private non-profit entities, such as universities, colleges, hospitals, laboratories, units of state and local governments and eligible agencies of the federal government.
- Post-doctoral fellows are not eligible to apply as co-investigators in this call.
How to Apply:
- Downolad the RFA overview and application template.
- Log in or create an account in the grant application portal.
- Submit your completed application.
- Email [email protected] with questions.
- Contact the Research office at [email protected] for assistance and if you decide to submit a proposal
Practical information
- Informed public
- Free
Organizer
- The Research Office